Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

5.4K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.4K
Conserved Binding Sites01:49

Conserved Binding Sites

4.9K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.9K
Conserved Binding Sites01:49

Conserved Binding Sites

1.9K
1.9K
Ligand Binding Sites02:40

Ligand Binding Sites

14.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ANARCII enables alignment-free antigen receptor numbering using a generalised language model.

Communications biology·2026
Same author

iNOS modulates inflammatory responses in an NO-independent manner through direct interaction with IRG1 in mitochondria.

Nature metabolism·2026
Same author

A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data.

Journal of chemical information and modeling·2026
Same author

Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization.

mAbs·2026
Same author

LICHEN enables light-chain immunoglobulin sequence generation conditioned on the heavy chain and experimental needs.

Communications biology·2026
Same author

Characterising nanobody developability to improve therapeutic design using the Therapeutic Nanobody Profiler.

Communications biology·2026

Related Experiment Video

Updated: Dec 14, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

925

Data Set Augmentation Allows Deep Learning-Based Virtual Screening to Better Generalize to Unseen Target Classes and

Jack Scantlebury1, Nathan Brown2, Frank Von Delft3,4,5

  • 1Department of Statistics, University of Oxford, 24-29 St Giles, Oxford OX1 3LB, U.K.

Journal of Chemical Information and Modeling
|July 24, 2020
PubMed
Summary
This summary is machine-generated.

Dataset augmentation improves deep learning for virtual screening by enabling models to better utilize protein structure information. This leads to more generalizable predictions and a focus on physical binding interactions.

More Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.1K
Avidity-based Extracellular Interaction Screening AVEXIS for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions
12:30

Avidity-based Extracellular Interaction Screening AVEXIS for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions

Published on: March 5, 2012

22.0K

Related Experiment Videos

Last Updated: Dec 14, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

925
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.1K
Avidity-based Extracellular Interaction Screening AVEXIS for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions
12:30

Avidity-based Extracellular Interaction Screening AVEXIS for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions

Published on: March 5, 2012

22.0K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Machine learning

Background:

  • Structure-based virtual screening (SBVS) is crucial for identifying drug candidates.
  • Current deep learning models in SBVS often underutilize protein structural data.
  • This limits their generalizability and ability to capture true binding physics.

Purpose of the Study:

  • To investigate the impact of dataset augmentation on deep learning models for SBVS.
  • To enhance the utilization of protein structural information in ligand binding prediction.
  • To improve model generalizability and focus on physical interactions over dataset biases.

Main Methods:

  • Implemented a simple dataset augmentation technique.
  • Trained deep learning models using augmented data, forcing protein structure incorporation.
  • Evaluated model performance on diverse protein-ligand complex datasets.

Main Results:

  • Augmented models demonstrated improved generalizability on unseen data distributions.
  • Models showed enhanced ability to identify key protein and ligand atoms involved in binding.
  • The approach successfully shifted model focus from dataset artifacts to physical binding principles.

Conclusions:

  • Dataset augmentation is an effective strategy to improve deep learning-based SBVS.
  • This method enhances model interpretability by highlighting important binding site residues and ligand atoms.
  • The findings pave the way for more accurate and reliable virtual screening tools.